89 related articles for article (PubMed ID: 28110661)
1. Understanding the process-induced formation of minor conformational variants of Erwinia chrysanthemil-asparaginase.
Gervais D; Hayzen J; Orphanou C; McEntee A; Hallam C; Brehm R
Enzyme Microb Technol; 2017 Mar; 98():26-33. PubMed ID: 28110661
[TBL] [Abstract][Full Text] [Related]
2. Capillary isoelectric focusing of a difficult-to-denature tetrameric enzyme using alkylurea-urea mixtures.
Gervais D; King D
Anal Biochem; 2014 Nov; 465():90-5. PubMed ID: 25132564
[TBL] [Abstract][Full Text] [Related]
3. L-Asparaginase from Erwinia Chrysanthemi 3937: cloning, expression and characterization.
Kotzia GA; Labrou NE
J Biotechnol; 2007 Jan; 127(4):657-69. PubMed ID: 16984804
[TBL] [Abstract][Full Text] [Related]
4. Acidic isoforms of Erwinase form part of the product: Correlation with clinical experience.
Gervais D
Biologicals; 2020 Mar; 64():28-33. PubMed ID: 31959505
[TBL] [Abstract][Full Text] [Related]
5. Structural Characterisation of Non-Deamidated Acidic Variants of Erwinia chrysanthemi L-asparaginase Using Small-Angle X-ray Scattering and Ion-Mobility Mass Spectrometry.
Gervais D; King D; Kanda P; Foote N; Elliott L; Brown P; Lee NO; Thalassinos K; Pizzey C; Rambo R; Minshull TC; Dickman MJ; Smith S
Pharm Res; 2015 Nov; 32(11):3636-48. PubMed ID: 26040662
[TBL] [Abstract][Full Text] [Related]
6. Rapid large-scale preparation of recombinant Erwinia chrysanthemi L-asparaginase.
Goward CR; Stevens GB; Tattersall R; Atkinson T
Bioseparation; 1992; 2(6):335-41. PubMed ID: 1368993
[TBL] [Abstract][Full Text] [Related]
7. Validation of a 30-year-old process for the manufacture of L-asparaginase from Erwinia chrysanthemi.
Gervais D; Allison N; Jennings A; Jones S; Marks T
Bioprocess Biosyst Eng; 2013 Apr; 36(4):453-60. PubMed ID: 22907565
[TBL] [Abstract][Full Text] [Related]
8. Cloning, expression and characterisation of Erwinia carotovora L-asparaginase.
Kotzia GA; Labrou NE
J Biotechnol; 2005 Oct; 119(4):309-23. PubMed ID: 15951039
[TBL] [Abstract][Full Text] [Related]
9. Atomic resolution structure of Erwinia chrysanthemi L-asparaginase.
Lubkowski J; Dauter M; Aghaiypour K; Wlodawer A; Dauter Z
Acta Crystallogr D Biol Crystallogr; 2003 Jan; 59(Pt 1):84-92. PubMed ID: 12499544
[TBL] [Abstract][Full Text] [Related]
10. A left-handed crossover involved in amidohydrolase catalysis. Crystal structure of Erwinia chrysanthemi L-asparaginase with bound L-aspartate.
Miller M; Rao JK; Wlodawer A; Gribskov MR
FEBS Lett; 1993 Aug; 328(3):275-9. PubMed ID: 8348975
[TBL] [Abstract][Full Text] [Related]
11. Structural Insight into Substrate Selectivity of Erwinia chrysanthemi L-asparaginase.
Nguyen HA; Su Y; Lavie A
Biochemistry; 2016 Mar; 55(8):1246-53. PubMed ID: 26855287
[TBL] [Abstract][Full Text] [Related]
12. One-step purification and kinetic properties of the recombinant L-asparaginase from Erwinia carotovora.
Krasotkina J; Borisova AA; Gervaziev YV; Sokolov NN
Biotechnol Appl Biochem; 2004 Apr; 39(Pt 2):215-21. PubMed ID: 15032742
[TBL] [Abstract][Full Text] [Related]
13. Recombinant deamidated mutants of Erwinia chrysanthemi L-asparaginase have similar or increased activity compared to wild-type enzyme.
Gervais D; Foote N
Mol Biotechnol; 2014 Oct; 56(10):865-77. PubMed ID: 24870616
[TBL] [Abstract][Full Text] [Related]
14. l-Asparaginase and HCP quantification by SWATH LC-MS/MS for new and improved purification step in Erwinia chrysanthemil-asparaginase manufacture.
Modi T; Regufe da Mota S; Gervais D
J Pharm Biomed Anal; 2022 Feb; 209():114537. PubMed ID: 34929569
[TBL] [Abstract][Full Text] [Related]
15. pH-Dependent Thermal Stability of Vibrio cholerae L-asparaginase.
Radha R; Gummadi SN
Protein Pept Lett; 2019; 26(10):743-750. PubMed ID: 31215369
[TBL] [Abstract][Full Text] [Related]
16. Purification and preliminary characterization of L-asparaginase from Erwinia aroideae NRRL B-138.
Tiwari N; Dua RD
Indian J Biochem Biophys; 1996 Oct; 33(5):371-6. PubMed ID: 9029817
[TBL] [Abstract][Full Text] [Related]
17. In vitro screening and in silico validation revealed key microbes for higher production of significant therapeutic enzyme l-asparaginase.
Vimal A; Kumar A
Enzyme Microb Technol; 2017 Mar; 98():9-17. PubMed ID: 28110669
[TBL] [Abstract][Full Text] [Related]
18. Safety profile of asparaginase Erwinia chrysanthemi in a large compassionate-use trial.
Plourde PV; Jeha S; Hijiya N; Keller FG; Silverman LB; Rheingold SR; Dreyer ZE; Dahl GV; Mercedes T; Lai C; Corn T
Pediatr Blood Cancer; 2014 Jul; 61(7):1232-8. PubMed ID: 24436152
[TBL] [Abstract][Full Text] [Related]
19. Development of a capillary zone electrophoresis method to quantify E. colil-asparaginase and its acidic variants.
Yao H; Vandenbossche J; Sänger-van de Griend CE; Janssens Y; Fernández CS; Xu X; Wynendaele E; Somsen GW; Haselberg R; De Spiegeleer B
Talanta; 2018 May; 182():83-91. PubMed ID: 29501203
[TBL] [Abstract][Full Text] [Related]
20. Purification and characterization of glutaminase-free L-asparaginase from Pectobacterium carotovorum MTCC 1428.
Kumar S; Venkata Dasu V; Pakshirajan K
Bioresour Technol; 2011 Jan; 102(2):2077-82. PubMed ID: 20832300
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
